Abstract

Economic and policy issues rein in industry enthusiasm for vaccines as an answer to drug-resistant bugs. Economic and policy issues rein in industry enthusiasm for vaccines as an answer to drug-resistant bugs.

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call